Marker Therapeutics (MRKR) Debt to Equity (2010 - 2023)

Marker Therapeutics (MRKR) reported Debt to Equity of $0.01 for Q1 2023, down 95.2% quarter-over-quarter from $0.13 in Q4 2022.

Marker Therapeutics (MRKR) Debt to Equity (2010 - 2023) Analysis & Trends

Marker Therapeutics (MRKR) has 12 years of Debt to Equity data on file, last reported at $0.01 in Q1 2023.

  • Debt to Equity for Q1 2023 came in at $0.01, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $0.01 (changed N/A YoY), and the FY2022 annual result was $0.13, changed N/A from the prior year.
  • Debt to Equity fell to $0.01 in Q1 2023 per MRKR's latest filing, from $0.13 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.29 in Q2 2022 and troughed at $0.0 in Q4 2019.
  • A 3-year average of $0.08 and a median of $0.0 in 2019 frame the typical range for Debt to Equity.
  • On a YoY basis, Debt to Equity climbed as much as 14.84% in 2019 and fell as far as 98.26% in 2019.
  • A 3-year view of Debt to Equity shows it stood at $0.0 in 2019, then jumped by 18038.53% to $0.13 in 2022, then tumbled by 95.2% to $0.01 in 2023.
  • Business Quant data shows MRKR's Debt to Equity at $0.01 in Q1 2023, $0.13 in Q4 2022, and $0.22 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Marker Therapeutics 28.20 Mn 28.20 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 0.01
Dec 31, 2022 0.13
Sep 30, 2022 0.22
Jun 30, 2022 0.29
Dec 31, 2019 0.00
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.00
Sep 30, 2018 0.15
Jun 30, 2018 0.04
Mar 31, 2018 0.01
Dec 31, 2017 0.00
Sep 30, 2017 0.00
Jun 30, 2017 0.00
Mar 31, 2017 0.00
Dec 31, 2016 0.00
Sep 30, 2016 0.00
Jun 30, 2016 -1.10
Mar 31, 2016 -1.15